Business News

Krka's Q3 Group Profit Lower Despite Higher Sales

Novo mesto, 15 November (STA) - The group around pharma company Krka posted a net profit of EUR 111.5m for the first three quarters of the year, down 3% over the same period in 2011, as operating profit (EBIT) dropped 15% to EUR 143.4m on the back of revenue that was up 6% to EUR 813.9m.

Group earnings before income tax, depreciation and amortisation (EBITDA) down almost 10% over the year before.

The core company saw sales rise 7% to EUR 752.3m, but net profit edged 1% lower to EUR 107.6m.

You might be also interested in:


We are here to help you.